Discover undervalued stocks with Eulerpool.

Subscribe for $2

Adapthealth Stock AHCO

Price

0
Today +/-
-0
Today %
-0 %

Adapthealth stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Adapthealth stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Adapthealth stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Adapthealth stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Adapthealth's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Adapthealth Stock Price History

DateAdapthealth Price
10/6/20250 undefined
10/3/20259.27 undefined
10/2/20259.20 undefined
10/1/20259.11 undefined
9/29/20258.95 undefined
9/28/20258.68 undefined
9/25/20258.89 undefined
9/24/20258.73 undefined
9/24/20258.90 undefined
9/23/20258.86 undefined
9/22/20258.86 undefined
9/19/20258.90 undefined
9/18/20259.15 undefined
9/17/20259.09 undefined
9/16/20259.12 undefined
9/15/20259.12 undefined
9/12/20259.43 undefined
9/11/20259.48 undefined
9/10/20259.21 undefined
9/9/20259.41 undefined
9/8/20259.34 undefined

Adapthealth Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Adapthealth, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Adapthealth from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Adapthealth’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Adapthealth. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Adapthealth’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Adapthealth’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Adapthealth’s growth potential.

Adapthealth Revenue, EBIT and net profit per share

DateAdapthealth RevenueAdapthealth EBITAdapthealth Net Income
2028e4.37 B undefined470.22 M undefined177.64 M undefined
2027e3.88 B undefined370.16 M undefined185.24 M undefined
2026e3.52 B undefined314.15 M undefined156.21 M undefined
2025e3.29 B undefined275.34 M undefined109.9 M undefined
20243.26 B undefined305.51 M undefined82.75 M undefined
20233.2 B undefined258.25 M undefined-678.9 M undefined
20222.97 B undefined190.4 M undefined63.4 M undefined
20212.45 B undefined217 M undefined141.8 M undefined
20201.06 B undefined57 M undefined-161.6 M undefined
2019529.6 M undefined29.4 M undefined-21.3 M undefined
20180 undefined-1.2 M undefined2.1 M undefined
20170 undefined0 undefined0 undefined

Adapthealth Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
201720182019202020212022202320242025e2026e2027e2028e
000.531.062.452.973.23.263.293.523.884.37
---99.62132.3921.037.741.880.896.8710.4112.50
--19.0916.9520.9516.8717.8123.7723.5622.0519.9717.75
001011795145015707750000
02-21-16114163-67882109156185177
---1,150.00666.67-187.58-55.32-1,176.19-112.0932.9343.1218.59-4.32
31.331.322.652.5133139134.16135.530000
- - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Adapthealth Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Adapthealth is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (k)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
20172018201920202021202220232024
               
0.10.976.9100149.646.377.13109.75
0078.6171.1359.9359.1388.91408.02
00000000
0013.258.8123.1127.8113.64139.84
00.212.733.437.452.169.3498.18
0.11.1181.4363.3670585.3649.02755.79
0063.6110.5546.3622637.53618.36
00000000
00000000
000116.1202.2162.8130.16105.55
000.2713.513.552.722.68
0.225334.8224.9319.3304.2366.98332.09
00.250.371.454.584.633.863.73
00.250.551.815.255.224.514.49
               
0240.600000.010.01
0000.562.112.132.152.16
02.1-40.3-199.2-4326.3-652.6-562.18
001.4-4.4-2.48.74.362.25
00000000
00.25-0.040.352.062.171.51.6
0.1086.3216.4293.9266.7257.87354.54
0.10.516.337.895.9100.8163.4113.39
00.229.9137.474.651.553.2568.49
2000000000
0021.530.435.437.262.4930.57
0.40.7154422499.8456.2537566.99
000.40.782.182.162.121.99
00000000
07.963.2333.1500.3448.4387.62352.29
00.010.461.112.682.612.52.34
00.010.611.533.183.063.042.91
00.250.571.895.255.234.544.51
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Adapthealth provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Adapthealth's financial health and stability.

Assets

Adapthealth's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Adapthealth must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Adapthealth after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Adapthealth's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
02-12-5815873-674
006282258351382
000-212218-62
00-1676-153-108-25
0-4371341561882
002335731080
001714140
0-160195275373480
00-21-39-203-391-337
0-248-84-815-1,824-411-357
0-248-63-775-1,621-19-19
0000000
000.190.351.38-0.04-0.05
0250105392291-11-28
00.250.080.641.6-0.07-0.09
01,000-214,000-103,000-71,000-18,000-12,000
0000000
00512349-10330
0-1.639.1155.872.4-17.5143.2
0000000

Adapthealth stock margins

The Adapthealth margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Adapthealth. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Adapthealth.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Adapthealth's sales revenue. A higher gross margin percentage indicates that the Adapthealth retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Adapthealth's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Adapthealth's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Adapthealth's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Adapthealth. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Adapthealth's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Adapthealth Margin History

Adapthealth Gross marginAdapthealth Profit marginAdapthealth EBIT marginAdapthealth Profit margin
2028e23.78 %10.77 %4.07 %
2027e23.78 %9.54 %4.77 %
2026e23.78 %8.94 %4.44 %
2025e23.78 %8.37 %3.34 %
202423.78 %9.37 %2.54 %
202317.82 %8.07 %-21.21 %
202216.87 %6.41 %2.13 %
202120.97 %8.84 %5.78 %
202017.03 %5.4 %-15.3 %
201919.13 %5.55 %-4.02 %
201823.78 %0 %0 %
201723.78 %0 %0 %

Adapthealth Stock Sales Revenue, EBIT, Earnings per Share

The Adapthealth earnings per share therefore indicates how much revenue Adapthealth has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Adapthealth earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Adapthealth's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Adapthealth’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Adapthealth's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Adapthealth Revenue, EBIT and net profit per share

DateAdapthealth Sales per ShareAdapthealth EBIT per shareAdapthealth Earnings per Share
2028e32.21 undefined0 undefined1.31 undefined
2027e28.64 undefined0 undefined1.37 undefined
2026e25.94 undefined0 undefined1.15 undefined
2025e24.27 undefined0 undefined0.81 undefined
202424.06 undefined2.25 undefined0.61 undefined
202323.85 undefined1.92 undefined-5.06 undefined
202221.37 undefined1.37 undefined0.46 undefined
202118.45 undefined1.63 undefined1.07 undefined
202020.12 undefined1.09 undefined-3.08 undefined
201923.43 undefined1.3 undefined-0.94 undefined
20180 undefined-0.04 undefined0.07 undefined
20170 undefined0 undefined0 undefined

Adapthealth business model

Adapthealth Corp is a leading provider of homecare products and services in the USA. It was founded in 2013 and is headquartered in Plymouth Meeting, Pennsylvania. The company started with the acquisition of NorthEast Respiratory Services (NERS), a regional provider of respiratory and sleep therapy devices in the USA. Since then, the company has made further acquisitions and expanded its range of homecare products and services. Adapthealth employs over 2,000 people and serves around half a million customers throughout North America. Its business model focuses on providing homecare products and services to help people live and care for themselves in their own homes. This includes respiratory therapy devices, sleep therapy devices, wheelchairs, walkers, and other medical aids. Adapthealth is an approved provider of Medicare and Medicaid services and works closely with insurance companies and healthcare facilities to offer its customers a wide range of products and services. Adapthealth is divided into different divisions in order to offer its customers the maximum possible range of services. These divisions are: Respiratory Therapy, Sleep Therapy, Mobility, Home Medical Equipment, and Hospice. The company aims to provide comprehensive care for its customers and offers not only product delivery and medical services, but also counseling and training. Adapthealth's employees are specialized and trained to meet the specific needs of each customer and provide the best possible care. In recent years, Adapthealth has expanded its range of homecare products and services through strategic acquisitions. One example is the acquisition of AeroCare Holdings Inc, a leading provider of home ventilators and related services in the USA. Through this acquisition, Adapthealth has further strengthened its position as a leading provider of homecare products and services in North America. In conclusion, Adapthealth Corp is a leading provider of homecare products and services in the USA. The company has demonstrated its ability to expand its activities through acquisitions and is committed to offering its customers a wide range of products and services. Adapthealth is known for its high standard of customer service and counseling, and its dedicated employees are able to meet the specific needs of each customer. Adapthealth is one of the most popular companies on Eulerpool.com.

Adapthealth SWOT Analysis

Strengths

Adapthealth Corp has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and market presence, which helps it stand out among competitors. Secondly, Adapthealth Corp has a diverse product and service portfolio, offering a wide range of healthcare solutions to meet various customer needs. Thirdly, the company has built robust relationships with healthcare providers and insurance companies, enabling seamless collaboration and greater market access.

Weaknesses

Adapthealth Corp also faces a few weaknesses that it needs to address. One weakness is its heavy reliance on third-party suppliers, which can create supply chain vulnerabilities and potential disruptions. Additionally, the company's geographic concentration of operations may expose it to regional economic risks or regulatory challenges. Furthermore, Adapthealth Corp might face difficulty in swiftly adapting to changing technology trends, potentially limiting its ability to stay at the forefront of innovative healthcare solutions.

Opportunities

Adapthealth Corp has several opportunities in the market that it can capitalize on. Firstly, the rising global healthcare expenditure presents a favorable growth environment for the company. Moreover, the increasing trend of remote patient monitoring and telehealth services creates opportunities for Adapthealth Corp to expand its offerings and reach new customer segments. Additionally, partnerships and collaborations with technology companies or startups can facilitate the development of cutting-edge healthcare solutions, enhancing Adapthealth Corp's competitive advantage.

Threats

Adapthealth Corp faces certain threats that pose risks to its business operations. Firstly, intense competition within the healthcare industry can erode market share and put pressure on pricing and profitability. Moreover, regulatory changes and uncertainties in healthcare policies can impact the company's operations and market dynamics. Additionally, the threat of cybersecurity breaches and data privacy concerns can undermine customer trust and negatively affect Adapthealth Corp's reputation. Economic downturns or financial instability may also pose a risk to the company's financial performance.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Adapthealth Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Adapthealth historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Adapthealth shares outstanding

The number of shares was Adapthealth in 2024 — This indicates how many shares 135.531 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Adapthealth earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Adapthealth's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Adapthealth’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Adapthealth's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Adapthealth.

Adapthealth latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20250.12 -0.13  (-210.83 %)2025 Q2
3/31/20250 -0.05  (-1,319.51 %)2025 Q1
12/31/20240.25 0.34  (35.51 %)2024 Q4
9/30/20240.17 0.15  (-11.4 %)2024 Q3
6/30/20240.16 0.13  (-19.35 %)2024 Q2
3/31/20240.05 -0.02  (-140.4 %)2024 Q1
12/31/20230.18 -1.91  (-1,157 %)2023 Q4
9/30/20230.19 0.42  (121.75 %)2023 Q3
6/30/20230.1 0.09  (-13.21 %)2023 Q2
3/31/20230.08 0.11  (39.77 %)2023 Q1
1
2
3

Eulerpool ESG Scorecard© for the Adapthealth stock

Eulerpool World ESG Rating (EESG©)

13/ 100

🌱 Environment

3

👫 Social

19

🏛️ Governance

17

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Adapthealth shareholders

%
Name
Stocks
Change
Date
10.25569 % BlackRock Institutional Trust Company, N.A.13,899,644-846,8126/30/2025
10.19559 % One Equity Partners LLC13,818,18006/30/2025
8.70061 % The Vanguard Group, Inc.11,792,025-394,8296/30/2025
7.30821 % Deerfield Management Company, L.P.9,904,895193,4856/30/2025
6.51048 % Fidelity Management & Research Company LLC8,823,7202,259,4086/30/2025
6.33098 % Skyknight Capital, L.P.8,580,44306/30/2025
5.60224 % Everest Hill Group Inc.7,592,778-1,051,9043/24/2024
5.39554 % Reinhart Partners, LLC7,312,62676,3646/30/2025
3.81655 % Dimensional Fund Advisors, L.P.5,172,611910,5836/30/2025
3.52687 % Jefferies LLC4,780,000841,6146/30/2025
1
2
3
4
5
...
10

Adapthealth Executives and Management Board

Mr. Jason Clemens

(46)
Adapthealth Chief Financial Officer
Compensation 2.38 M

Mr. Albert Prast

(63)
Adapthealth Chief Technology Officer
Compensation 1.8 M

Mr. Shaw Rietkerk

(49)
Adapthealth Chief Business Officer
Compensation 1.53 M

Mr. Terence Connors

(69)
Adapthealth Independent Director
Compensation 307,576

Mr. Bradley Coppens

(42)
Adapthealth Independent Director
Compensation 306,674
1
2
3
4

Most common questions regarding Adapthealth

What values and corporate philosophy does Adapthealth represent?

Adapthealth Corp represents values of innovation, compassion, and patient-centered care. With a strong corporate philosophy that focuses on improving healthcare outcomes, the company aims to provide adaptable and high-quality health solutions to individuals in need. Adapthealth Corp prioritizes delivering efficient and personalized services by leveraging advancements in technology and medical expertise. By constantly adapting to the ever-evolving healthcare landscape, the company ensures that patients receive the best possible care and support. Adapthealth Corp is committed to enhancing the overall well-being of individuals and optimizing their healthcare experiences through their range of products and services.

In which countries and regions is Adapthealth primarily present?

Adapthealth Corp is primarily present in the United States.

What significant milestones has the company Adapthealth achieved?

Adapthealth Corp has achieved several significant milestones throughout its history. The company has successfully established itself as a leader in the healthcare industry, providing innovative and personalized solutions to patients. Adapthealth Corp has expanded its operations, building a strong nationwide presence. It has formed strategic partnerships with healthcare providers, enabling it to offer comprehensive and high-quality services. The company has achieved notable financial growth, consistently delivering impressive results. Adapthealth Corp's commitment to patient care and continuous innovation has earned it industry recognition and an excellent reputation. These milestones highlight Adapthealth Corp's success in establishing itself as a reliable and trusted healthcare company.

What is the history and background of the company Adapthealth?

Founded in 2012, Adapthealth Corp is a renowned healthcare company providing home medical equipment and services. It has emerged as a leading player in the industry, specializing in respiratory and home medical equipment for patients with chronic illnesses and mobility challenges. Adapthealth Corp offers a wide range of products, including respiratory and sleep therapy equipment, power mobility products, and other durable medical equipment. With a customer-centric approach, the company strives to improve patients' quality of life by ensuring easy access to personalized healthcare solutions. Adapthealth Corp's commitment to innovation, quality service, and patient care has made it a trusted name in the industry.

Who are the main competitors of Adapthealth in the market?

Some of the main competitors of Adapthealth Corp in the market include Medline Industries, Inc., Byram Healthcare, McKesson Corporation, Lincare Holdings Inc., and Apria Healthcare Group Inc.

In which industries is Adapthealth primarily active?

Adapthealth Corp is primarily active in the healthcare industry.

What is the business model of Adapthealth?

The business model of Adapthealth Corp is focused on providing home healthcare equipment and related services. They offer a wide range of products including respiratory equipment, mobility devices, and home medical equipment to individuals with chronic illnesses or recovering from surgery. Adapthealth Corp operates through a combination of direct-to-patient delivery, retail locations, and partnerships with healthcare providers. Their goal is to improve patient outcomes by delivering high-quality equipment and personalized care. Adapthealth Corp aims to enhance patients' independence and quality of life by enabling them to receive healthcare services in the comfort of their own homes.

What is the P/E ratio of Adapthealth 2025?

The P/E ratio cannot be calculated for Adapthealth at the moment.

What is the P/S ratio of Adapthealth 2025?

The P/S cannot be calculated for Adapthealth currently.

What is the Quality Investing of Adapthealth?

The Quality Investing for Adapthealth is 2/10.

What is the revenue of Adapthealth 2025?

The expected Adapthealth revenue is 3.29 B USD.

How high is the profit of Adapthealth 2025?

The expected Adapthealth profit is 109.9 M USD.

What is the business model of Adapthealth

AdaptHealth Corp is a leading provider of home medical products in the USA, offering a wide range of products and services tailored to the individual needs of its customers. The company was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania. AdaptHealth Corp is divided into three segments: Respiratory & HME Services, Diabetes Care, and Hospital Bed & Support Surfaces. These segments offer a wide range of products and services, including respiratory devices, masks and accessories, patient lifts, wheelchairs, walkers, and many other medical aids. The Respiratory & HME Services segment is the largest segment and includes a variety of products tailored to the needs of patients with respiratory problems and disabilities. This includes respiratory therapy devices such as CPAP and BiPAP machines, oxygen concentrators, ventilators, and other aids such as mobility scooters and wheelchairs. The company also offers HME products, including hospital beds, pressure-relief mattresses, forearm crutches, and other products that meet the daily needs of a sick or disabled individual. The Diabetes Care segment offers a wide range of diabetes management products, including blood glucose meters, insulin pumps, test strips, and many other aids. The diabetes division supports patients through training and individual consultations, providing comprehensive and specialized care. The Hospital Bed & Support Surfaces segment offers products and services such as patient lifts, wheelchairs, walkers, and other equipment that are provided to hospitals and nursing homes. This segment is an important part of the company and provides solutions that meet the daily needs of medical facilities. AdaptHealth Corp offers its customers a comprehensive service package. The company delivers products directly to the home, organizes repairs and maintenance, provides training and consultations on product usage. In this way, the company supports its customers at every stage of their treatment and provides comprehensive service, from diagnosis to rehabilitation. AdaptHealth Corp also offers a variety of online services, such as the ability to place orders online and manage invoices. Additionally, the company offers its own app that allows customers to manage their orders and appointments on the go. In summary, AdaptHealth Corp is a leading provider of home medical products in the USA, offering a wide range of specialized products and comprehensive services. The company is able to provide customized solutions to meet the needs of its customers, ensuring they receive optimal medical care.

What is the Adapthealth dividend?

Adapthealth pays a dividend of 0 USD distributed over payouts per year.

How often does Adapthealth pay dividends?

The dividend cannot currently be calculated for Adapthealth or the company does not pay out a dividend.

What is the Adapthealth ISIN?

The ISIN of Adapthealth is US00653Q1022.

What is the Adapthealth WKN?

The WKN of Adapthealth is A2JR26.

What is the Adapthealth ticker?

The ticker of Adapthealth is AHCO.

How much dividend does Adapthealth pay?

Over the past 12 months, Adapthealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Adapthealth is expected to pay a dividend of 0 USD.

What is the dividend yield of Adapthealth?

The current dividend yield of Adapthealth is .

When does Adapthealth pay dividends?

Adapthealth pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Adapthealth?

Adapthealth paid dividends every year for the past 0 years.

What is the dividend of Adapthealth?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Adapthealth located?

Adapthealth is assigned to the 'Health' sector.

Wann musste ich die Aktien von Adapthealth kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Adapthealth from 10/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2025.

When did Adapthealth pay the last dividend?

The last dividend was paid out on 10/6/2025.

What was the dividend of Adapthealth in the year 2024?

In the year 2024, Adapthealth distributed 0 USD as dividends.

In which currency does Adapthealth pay out the dividend?

The dividends of Adapthealth are distributed in USD.

All fundamentals about Adapthealth

Our stock analysis for Adapthealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adapthealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.